Immunotherapy is kind to your body

GcMAF, or Gc protein-derived Macrophage Activating Factor, is a protein that we have studied for 19 years for its potential therapeutic effects, particularly in immune system modulation. Our
research has shown that GcMAF can activate macrophages, which are crucial cells in the immune system responsible for engulfing and destroying pathogens and cancer cells. Our studies have explored the effects of GcMAF on various conditions. For instance, we have been investigating GcMAF for its potential benefits in treating autism. Our research indicates that GcMAF can normalize dysregulated gene expression in the endocannabinoid system of autistic patients, improving immune function . Additionally, GcMAF has shown promise in cancer research, where we have observed GcMAF inhibitimg the growth of cancer cells and enhance the immune response against tumours
Overall. Our GcMAF research is ongoing.